Kecit-P Tablet contains a combination of Citicoline (500 mg) and Piracetam (800 mg), which are widely used nootropic agents indicated for cognitive enhancement and neuroprotection. Citicoline, a neuroprotective agent, acts as a precursor for the synthesis of phosphatidylcholine, an essential component of neuronal membranes, thereby promoting membrane repair and enhancing neurotransmitter synthesis, particularly acetylcholine. Piracetam, a cyclic derivative of GABA, modulates neuronal excitability and improves neuroplasticity by facilitating synaptic transmission and increasing cerebral blood flow. The synergistic action of these agents supports cognitive functions such as memory, attention, and learning, making Kecit-P beneficial in the management of cognitive impairments associated with cerebrovascular diseases, traumatic brain injury, dementia, and age-related cognitive decline. Additionally, this combination may aid in the recovery of neurological deficits following stroke or brain injury by enhancing neuronal metabolism and protecting against oxidative stress. Kecit-P is generally well tolerated; however, it should be used under medical supervision, especially in patients with a history of seizures or renal impairment. Dosage and duration of therapy should be individualized based on clinical response and patient condition.